| Year |
Citation |
Score |
| 2023 |
Lee EJ, Lee KJ, Jung S, Park KH, Park SI. Mobilization of monocytic myeloid-derived suppressor cells is regulated by PTH1R activation in bone marrow stromal cells. Bone Research. 11: 22. PMID 37085481 DOI: 10.1038/s41413-023-00255-y |
0.33 |
|
| 2020 |
Whang YM, Yoon DH, Hwang GY, Yoon H, Park SI, Choi YW, Chang IH. Liposome-Encapsulated Bacillus Calmette-Guérin Cell Wall Skeleton Enhances Antitumor Efficiency for Bladder Cancer In Vitro and In Vivo via Induction of AMP-Activated Protein Kinase. Cancers. 12. PMID 33302414 DOI: 10.3390/cancers12123679 |
0.338 |
|
| 2020 |
Lee SH, Lee YJ, Park SI, Kim JE. Unique cartilage matrix-associated protein inhibits the migratory and invasive potential of triple-negative breast cancer. Biochemical and Biophysical Research Communications. PMID 32768190 DOI: 10.1016/J.Bbrc.2020.07.114 |
0.439 |
|
| 2020 |
Park S, Lee KJ, Lee EJ, Whang YM, Cho SW. Abstract P5-04-29: Osteoblasts regulate mobilization of the myeloid-derived suppressor cells from the bone marrow of breast cancer patients Cancer Research. 80. DOI: 10.1158/1538-7445.Sabcs19-P5-04-29 |
0.471 |
|
| 2020 |
Cho SWW, Lee K, Kim T, Park SI, Im S. Abstract P2-19-02: Circulating osteocalcin-positive cells as a novel diagnostic biomarker for bone metastasis in breast cancer patients Cancer Research. 80. DOI: 10.1158/1538-7445.Sabcs19-P2-19-02 |
0.39 |
|
| 2019 |
Kim MJ, Hwang GY, Cho MJ, Chi BH, Park SI, Chang IH, Whang YM. Depletion of NBR1 in urothelial carcinoma cells enhances rapamycin-induced apoptosis through impaired autophagy and mitochondrial dysfunction. Journal of Cellular Biochemistry. PMID 31297862 DOI: 10.1002/Jcb.29248 |
0.401 |
|
| 2019 |
Pativada T, Kim MH, Lee JH, Hong SS, Choi CW, Choi YH, Kim WJ, Song DW, Park SI, Lee EJ, Seo BY, Kim H, Kim HK, Lee KH, Ahn SK, et al. Benzylideneacetone Derivatives Inhibit Osteoclastogenesis and Activate Osteoblastogenesis Independently Based on Specific Structure-Activity Relationship. Journal of Medicinal Chemistry. PMID 31257875 DOI: 10.1021/Acs.Jmedchem.9B00270 |
0.316 |
|
| 2019 |
Kang J, Choi YJ, Seo BY, Jo U, Park SI, Kim YH, Park KH. A Selective FGFR inhibitor AZD4547 suppresses RANKL/M-CSF/OPG-dependent ostoclastogenesis and breast cancer growth in the metastatic bone microenvironment. Scientific Reports. 9: 8726. PMID 31217507 DOI: 10.1038/S41598-019-45278-W |
0.471 |
|
| 2019 |
Seol MA, Kim JH, Oh K, Kim G, Seo MW, Shin YK, Sim JH, Shin HM, Seo BY, Lee DS, Ku JL, Han I, Kang I, Park SI, Kim HR. Interleukin-7 Contributes to the Invasiveness of Prostate Cancer Cells by Promoting Epithelial-Mesenchymal Transition. Scientific Reports. 9: 6917. PMID 31061414 DOI: 10.1038/S41598-019-43294-4 |
0.4 |
|
| 2019 |
Whang YM, Jung SP, Kim MK, Chang IH, Park SI. Targeting the Hepatocyte Growth Factor and c-Met Signaling Axis in Bone Metastases. International Journal of Molecular Sciences. 20. PMID 30658428 DOI: 10.3390/Ijms20020384 |
0.405 |
|
| 2019 |
Jeong M, Jo S, Park S, Sohn J, Park YG. Abstract 4745: Reversal by inhibiting XBP1 activation of glucose deprivation-induced tolerance to multiple anticancer therapies Cancer Research. 79: 4745-4745. DOI: 10.1158/1538-7445.Am2019-4745 |
0.386 |
|
| 2018 |
Lee KJ, Park SI, Jeong S, Choi EK. Abstract 3702: A novel nanoparticle-based theranostic agent targeting low-density lipoprotein receptor-related protein-1 enhances the efficacy of neoadjuvant radiotherapy in colorectal cancer Cancer Research. 78: 3702-3702. DOI: 10.1158/1538-7445.Am2018-3702 |
0.369 |
|
| 2017 |
Lee C, Whang YM, Campbell P, Mulcrone PL, Elefteriou F, Cho SW, Park SI. Dual targeting c-met and VEGFR2 in osteoblasts suppresses growth and osteolysis of prostate cancer bone metastasis. Cancer Letters. 414: 205-213. PMID 29174801 DOI: 10.1016/J.Canlet.2017.11.016 |
0.489 |
|
| 2017 |
Whang YM, Jin SB, Park SI, Chang IH. MEK inhibition enhances efficacy of bacillus Calmette-Guérin on bladder cancer cells by reducing release of Toll-like receptor 2-activated antimicrobial peptides. Oncotarget. 8: 53168-53179. PMID 28881802 DOI: 10.18632/Oncotarget.18230 |
0.419 |
|
| 2016 |
Jeong HM, Cho SW, Park SI. Osteoblasts Are the Centerpiece of the Metastatic Bone Microenvironment. Endocrinology and Metabolism (Seoul, Korea). 31: 485-492. PMID 28029019 DOI: 10.3803/Enm.2016.31.4.485 |
0.49 |
|
| 2015 |
Park SI, Park SJ, Lee J, Kim HE, Park SJ, Sohn JW, Park YG. Inhibition of Cyclic AMP Response Element-directed Transcription by Decoy Oligonucleotides Enhances Tumor-Specific Radiosensitivity. Biochemical and Biophysical Research Communications. PMID 26655813 DOI: 10.1016/J.Bbrc.2015.11.122 |
0.433 |
|
| 2015 |
Soki FN, Cho SW, Kim YW, Jones JD, Park SI, Koh AJ, Entezami P, Daignault-Newton S, Pienta KJ, Roca H, McCauley LK. Bone marrow macrophages support prostate cancer growth in bone. Oncotarget. PMID 26459393 DOI: 10.18632/Oncotarget.6042 |
0.467 |
|
| 2015 |
Kim HS, Lim JM, Kim JY, Kim Y, Park S, Sohn J. Panaxydol, a component of Panax ginseng, induces apoptosis in cancer cells through EGFR activation and ER stress and inhibits tumor growth in mouse models. International Journal of Cancer. Journal International Du Cancer. PMID 26421996 DOI: 10.1002/Ijc.29879 |
0.347 |
|
| 2015 |
Whang YM, Park SI, Trenary IA, Egnatchik RA, Fessel JP, Kaufman JM, Carbone DP, Young JD. LKB1 deficiency enhances sensitivity to energetic stress induced by erlotinib treatment in non-small-cell lung cancer (NSCLC) cells. Oncogene. PMID 26119936 DOI: 10.1038/Onc.2015.140 |
0.403 |
|
| 2014 |
Kim SD, Lee YJ, Baik JS, Han JY, Lee CG, Heo K, Park YS, Kim JS, Ji HD, Park SI, Rhee MH, Yang K. Baicalein inhibits agonist- and tumor cell-induced platelet aggregation while suppressing pulmonary tumor metastasis via cAMP-mediated VASP phosphorylation along with impaired MAPKs and PI3K-Akt activation. Biochemical Pharmacology. 92: 251-65. PMID 25268843 DOI: 10.1016/j.bcp.2014.09.019 |
0.32 |
|
| 2014 |
Buenrostro D, Park SI, Sterling JA. Dissecting the role of bone marrow stromal cells on bone metastases. Biomed Research International. 2014: 875305. PMID 25054153 DOI: 10.1155/2014/875305 |
0.439 |
|
| 2014 |
Cho SW, Soki FN, Koh AJ, Eber MR, Entezami P, Park SI, van Rooijen N, McCauley LK. Osteal macrophages support physiologic skeletal remodeling and anabolic actions of parathyroid hormone in bone. Proceedings of the National Academy of Sciences of the United States of America. 111: 1545-50. PMID 24406853 DOI: 10.1073/Pnas.1315153111 |
0.375 |
|
| 2014 |
Zhang H, Yu C, Dai J, Keller JM, Hua A, Sottnik JL, Shelley G, Hall CL, Park SI, Yao Z, Zhang J, McCauley LK, Keller ET. Parathyroid hormone-related protein inhibits DKK1 expression through c-Jun-mediated inhibition of β-catenin activation of the DKK1 promoter in prostate cancer. Oncogene. 33: 2464-77. PMID 23752183 DOI: 10.1038/Onc.2013.203 |
0.466 |
|
| 2014 |
Lee C, Campbell P, Whang YM, Young JD, Elefteriou F, Park SI. Abstract 1172: Targeting c-Met and VEGFR2 in the stromal compartment of prostate cancer bone metastasis Cancer Research. 74: 1172-1172. DOI: 10.1158/1538-7445.Am2014-1172 |
0.527 |
|
| 2013 |
Park SI, Lee C, Sadler WD, Koh AJ, Jones J, Seo JW, Soki FN, Cho SW, Daignault SD, McCauley LK. Parathyroid hormone-related protein drives a CD11b+Gr1+ cell-mediated positive feedback loop to support prostate cancer growth. Cancer Research. 73: 6574-83. PMID 24072746 DOI: 10.1158/0008-5472.Can-12-4692 |
0.535 |
|
| 2013 |
Jin R, Sterling JA, Edwards JR, DeGraff DJ, Lee C, Park SI, Matusik RJ. Activation of NF-kappa B signaling promotes growth of prostate cancer cells in bone. Plos One. 8: e60983. PMID 23577181 DOI: 10.1371/Journal.Pone.0060983 |
0.513 |
|
| 2013 |
Ding X, Park SI, McCauley LK, Wang CY. Signaling between transforming growth factor β (TGF-β) and transcription factor SNAI2 represses expression of microRNA miR-203 to promote epithelial-mesenchymal transition and tumor metastasis. The Journal of Biological Chemistry. 288: 10241-53. PMID 23447531 DOI: 10.1074/Jbc.M112.443655 |
0.313 |
|
| 2012 |
Soki FN, Park SI, McCauley LK. The multifaceted actions of PTHrP in skeletal metastasis. Future Oncology (London, England). 8: 803-17. PMID 22830401 DOI: 10.2217/Fon.12.76 |
0.442 |
|
| 2012 |
Jung Y, Shiozawa Y, Wang J, McGregor N, Dai J, Park SI, Berry JE, Havens AM, Joseph J, Kim JK, Patel L, Carmeliet P, Daignault S, Keller ET, McCauley LK, et al. Prevalence of prostate cancer metastases after intravenous inoculation provides clues into the molecular basis of dormancy in the bone marrow microenvironment. Neoplasia (New York, N.Y.). 14: 429-39. PMID 22745589 DOI: 10.1596/Neo.111740 |
0.48 |
|
| 2012 |
Park SI, Liao J, Berry JE, Li X, Koh AJ, Michalski ME, Eber MR, Soki FN, Sadler D, Sud S, Tisdelle S, Daignault SD, Nemeth JA, Snyder LA, Wronski TJ, et al. Cyclophosphamide creates a receptive microenvironment for prostate cancer skeletal metastasis. Cancer Research. 72: 2522-32. PMID 22589273 DOI: 10.1158/0008-5472.Can-11-2928 |
0.482 |
|
| 2012 |
Park SI, McCauley LK. Nuclear localization of parathyroid hormone-related peptide confers resistance to anoikis in prostate cancer cells. Endocrine-Related Cancer. 19: 243-54. PMID 22291434 DOI: 10.1530/Erc-11-0278 |
0.505 |
|
| 2011 |
Park SI, Soki FN, McCauley LK. Roles of bone marrow cells in skeletal metastases: no longer bystanders. Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society. 4: 237-46. PMID 21809058 DOI: 10.1007/S12307-011-0081-8 |
0.443 |
|
| 2011 |
Li X, Liao J, Park SI, Koh AJ, Sadler WD, Pienta KJ, Rosol TJ, McCauley LK. Drugs which inhibit osteoclast function suppress tumor growth through calcium reduction in bone. Bone. 48: 1354-61. PMID 21419883 DOI: 10.1016/J.Bone.2011.03.687 |
0.473 |
|
| 2011 |
Li X, Koh AJ, Wang Z, Soki FN, Park SI, Pienta KJ, McCauley LK. Inhibitory effects of megakaryocytic cells in prostate cancer skeletal metastasis. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 26: 125-34. PMID 20684002 DOI: 10.1002/Jbmr.204 |
0.533 |
|
| 2010 |
Park SI, Kim SJ, McCauley LK, Gallick GE. Pre-clinical mouse models of human prostate cancer and their utility in drug discovery. Current Protocols in Pharmacology / Editorial Board, S.J. Enna (Editor-in-Chief) ... [Et Al.]. Unit 14.15. PMID 21483646 DOI: 10.1002/0471141755.Ph1415S51 |
0.627 |
|
| 2010 |
Park SI, Li X, Berry JE, Koh AJ, Wang J, Taichman R, McCauley LK. Abstract 5039: Novel insight into mechanisms of parathyroid hormone-related protein (PTHrP) action in prostate cancer growth and skeletal metastasis: Altered anoikis and angiogenesis Cancer Research. 70: 5039-5039. DOI: 10.1158/1538-7445.Am10-5039 |
0.504 |
|
| 2010 |
Chirgwin JM, Edwards CM, Pedersen EA, Shiozawa Y, Taichman RS, Park SI, McCauley LK, Matsumoto T, Abe M. Meeting report from the IX international meeting on cancer induced bone disease Ibms Bonekey. 7: 32-46. DOI: 10.1138/20100426 |
0.386 |
|
| 2009 |
Kopetz S, Lesslie DP, Dallas NA, Park SI, Johnson M, Parikh NU, Kim MP, Abbruzzese JL, Ellis LM, Chandra J, Gallick GE. Synergistic activity of the SRC family kinase inhibitor dasatinib and oxaliplatin in colon carcinoma cells is mediated by oxidative stress. Cancer Research. 69: 3842-9. PMID 19383922 DOI: 10.1158/0008-5472.CAN-08-2246 |
0.588 |
|
| 2009 |
Kim MP, Park SI, Kopetz S, Gallick GE. Src family kinases as mediators of endothelial permeability: effects on inflammation and metastasis. Cell and Tissue Research. 335: 249-59. PMID 18815812 DOI: 10.1007/S00441-008-0682-9 |
0.613 |
|
| 2008 |
Park SI, Zhang J, Phillips KA, Araujo JC, Najjar AM, Volgin AY, Gelovani JG, Kim SJ, Wang Z, Gallick GE. Targeting SRC family kinases inhibits growth and lymph node metastases of prostate cancer in an orthotopic nude mouse model. Cancer Research. 68: 3323-33. PMID 18451159 DOI: 10.1158/0008-5472.Can-07-2997 |
0.671 |
|
| 2007 |
Shah AN, Summy JM, Zhang J, Park SI, Parikh NU, Gallick GE. Development and characterization of gemcitabine-resistant pancreatic tumor cells. Annals of Surgical Oncology. 14: 3629-37. PMID 17909916 DOI: 10.1245/S10434-007-9583-5 |
0.6 |
|
| 2007 |
Zhang J, Park SI, Artime MC, Summy JM, Shah AN, Bomser JA, Dorfleutner A, Flynn DC, Gallick GE. AFAP-110 is overexpressed in prostate cancer and contributes to tumorigenic growth by regulating focal contacts. The Journal of Clinical Investigation. 117: 2962-73. PMID 17885682 DOI: 10.1172/Jci30710 |
0.62 |
|
| 2007 |
Park SI, Shah AN, Zhang J, Gallick GE. Regulation of angiogenesis and vascular permeability by Src family kinases: opportunities for therapeutic treatment of solid tumors. Expert Opinion On Therapeutic Targets. 11: 1207-17. PMID 17845146 DOI: 10.1517/14728222.11.9.1207 |
0.63 |
|
| 2001 |
Park YG, Park S, Lim SO, Lee MS, Ryu CK, Kim I, Cho-Chung YS. Reduction in cyclin D1/Cdk4/retinoblastoma protein signaling by CRE-decoy oligonucleotide Biochemical and Biophysical Research Communications. 281: 1213-1219. PMID 11243864 DOI: 10.1006/Bbrc.2001.4521 |
0.363 |
|
| Show low-probability matches. |